Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients


Photo credits: npr.org


Monoclonal antibody drugs are supposed to help people with mild to moderate COVID-19 avoid the hospital, but it can be a challenge to find out where the treatment is offered.


These are drugs available nationwide through emergency authorization. They're designed to bind to the coronavirus to prevent it from invading cells. The government allocates the drug to states, which in turn decides how the drugs are distributed. Uptake has been irregular, in part because the medicines are cumbersome to deliver – they're given by infusion.


For more information please check out the full article right here.

0 comments

© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.